Martin Yang, Oppenheimer senior analyst, joins 'Squawk on the Street' to discuss what Apple Intelligence is lacking that's ...
According to estimates by IDC and Canalys, overall iPhone market share fell 1% year over year in Q4 to 23% despite the ...
Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...
Investors were hoping that Apple Intelligence would drive a wave of iPhone upgrades. How's that playing out? This will be the first full quarter of results from Apple since the company's iPhone 16 ...
Apple’s approach to AI spending continues to lag behind its "Magnificent Seven" peers, a strategy that's drawn mixed ...